Personalized treatment for sleep apnea and its effects on Alzheimer's in Black patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the effectiveness of a personalized treatment adherence model for obstructive sleep apnea (OSA) called PRAISE, aimed at improving patient compliance with the recommended Positive Airway Pressure (PAP) treatment. The study focuses on African American and Black individuals aged 60-85 who have been diagnosed with OSA. By assessing the impact of this personalized approach on Alzheimer's disease biomarkers and cognitive function, the study seeks to provide insights into the intersection of sleep apnea and cognitive health in this demographic.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Self-reported race/ethnicity as African American, African, Afro-latino, Caribbean or black
* Ages 55-85 years
* accessible by phone
* OSA diagnosis
* consent, including permission to release medical data

Exclusion Criteria:

* progressive illnesses in which disability or death is expected within 1 year
* impaired cognitive/ functional ability precluding participation
* intention to move within the year
* and a family member currently enrolled.

Where it's running

• University of Miami
  Miami, Florida, United States Recruiting

Study contacts

• Principal investigator: Girardin Jean-Louis, PhD — University of Miami
• Study coordinator: Girardin Jean-Louis, PhD
• Email: girardin.jean-louis@miami.edu
• Phone: 3052430776

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oura Ring validation for sleep using gold-standard sleep tests

  This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.

  Recruiting Ouraring Inc. · St Louis, Missouri · NCT07908199

• Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities

  This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857044

• Using a sleep medication to help people with obstructive sleep apnea tolerate CPAP

  The trial will test whether giving the sleep medicine eszopiclone to people with obstructive sleep apnea (AHI ≥10/hour) helps them stick with CPAP and improves thinking skills.

  Recruiting Phase 3 Yale University · North Haven, Connecticut · NCT07332442

• Neurostimulation treatment for sleep-disordered breathing

  This trial will test whether the Lunair Alpha System, a small implanted neurostimulator, can reduce breathing problems during sleep for people with moderate to severe sleep apnea who cannot tolerate or access other treatments.

  Recruiting Lunair Medical · Panama City, Provincia de Panamá · NCT07243405

• IBI362 for Chinese adults with obstructive sleep apnea and BMI ≥28

  This trial will see if once-weekly IBI362 injections help Chinese adults with moderate-to-severe obstructive sleep apnea who have a BMI of 28 or higher.

  Recruiting Phase 3 Innovent Biologics (Suzhou) Co. Ltd. · Beijing · NCT06931028

• Neurostimulation treatment for sleep apnea

  This study tests a new implant that uses neurostimulation to see if it can help people with moderate to severe sleep apnea who can't use regular treatments.

  Recruiting Lunair Medical · Asunción, Paraguay · NCT06883617

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.